NGG vs. GSK
NGG (National Grid plc) and GSK (GSK plc) are both stocks. NGG operates in Utilities - Regulated Electric (Utilities), while GSK operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, NGG returned 6.81%/yr vs 3.76%/yr for GSK. Their 0.40 correlation means their historical movements had little consistent relationship.
Performance
NGG vs. GSK - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NGG achieves a 6.11% return, which is significantly lower than GSK's 7.22% return. Over the past 10 years, NGG has outperformed GSK with an annualized return of 6.81%, while GSK has yielded a comparatively lower 3.76% annualized return.
NGG
- 1D
- -0.52%
- 1M
- -3.48%
- 6M
- -3.75%
- YTD
- 6.11%
- 1Y
- 15.90%
- 3Y*
- 14.50%
- 5Y*
- 11.07%
- 10Y*
- 6.81%
- ALL TIME*
- 8.33%
GSK
- 1D
- -0.73%
- 1M
- -3.67%
- 6M
- 1.90%
- YTD
- 7.22%
- 1Y
- 42.78%
- 3Y*
- 18.53%
- 5Y*
- 4.82%
- 10Y*
- 3.76%
- ALL TIME*
- 8.48%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
GSK GSK plc | $276.89M | $237.83M | $206.74M |
| $62.39M | $64.89M | $105.15M |
NGG vs. GSK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NGG National Grid plc | 6.11% | 35.88% | -1.26% | 18.82% | -12.68% | 29.02% | -0.75% | 38.53% | -13.76% | 4.94% |
GSK GSK plc | 7.22% | 51.23% | -5.14% | 9.71% | -33.41% | 26.74% | -17.72% | 29.24% | 13.79% | -2.97% |
Correlation
The correlation between NGG and GSK is 0.36, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.36 |
Correlation (3Y) Balances recent behavior with more history. | 0.36 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.40 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.42 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2001 | 0.40 |
Fundamentals
NGG:
$80.40B
GSK:
$103.56B
NGG:
£6.16
GSK:
£2.36
NGG:
9.65
GSK:
16.25
NGG:
0.25
GSK:
0.36
NGG:
1.65
GSK:
2.36
NGG:
1.50
GSK:
4.45
NGG:
£35.68B
GSK:
£33.25B
NGG:
£10.47B
GSK:
£24.35B
NGG:
£15.03B
GSK:
£10.68B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NGG vs. GSK — Risk / Return Rank
NGG
GSK
NGG vs. GSK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for National Grid plc (NGG) and GSK plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NGG | GSK | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.83 | ||
| Sortino ratioReturn per unit of downside risk | -1.23 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.29 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 1.30 | 2.41 | -1.11 |
| Martin ratioReturn relative to average drawdown | 3.02 | 5.24 | -2.22 |
Loading charts...
Drawdowns
NGG vs. GSK - Drawdown Comparison
The maximum NGG drawdown since its inception was -54.85%, roughly equal to the maximum GSK drawdown of -55.70%. Use the drawdown chart below to compare losses from any high point for NGG and GSK.
Loading charts...
Drawdown Indicators
| NGG | GSK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.85% | -55.70% | +0.85% |
Max Drawdown (1Y)Largest decline over 1 year | -14.15% | -18.53% | +4.38% |
Max Drawdown (3Y)Largest decline over 3 years | -20.76% | -28.46% | +7.70% |
Max Drawdown (5Y)Largest decline over 5 years | -39.20% | -50.10% | +10.90% |
Max Drawdown (10Y)Largest decline over 10 years | -39.20% | -50.10% | +10.90% |
Current DrawdownCurrent decline from peak | -12.62% | -14.05% | +1.43% |
Average DrawdownAverage peak-to-trough decline | -13.39% | -18.85% | +5.46% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.06% | 8.49% | -2.43% |
Volatility
NGG vs. GSK - Volatility Comparison
The current volatility for National Grid plc (NGG) is 6.64%, while GSK plc (GSK) has a volatility of 8.74%. This indicates that NGG experiences smaller price fluctuations and is considered to be less risky than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NGG | GSK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.64% | 8.74% | -2.10% |
Volatility (6M)Calculated over the trailing 6-month period | 18.30% | 19.87% | -1.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.46% | 26.94% | -5.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.32% | 25.39% | -3.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.03% | 22.97% | +0.06% |
Dividends
NGG vs. GSK - Dividend Comparison
NGG's dividend yield for the trailing twelve months is around 4.05%, more than GSK's 3.47% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GSK plc | 3.47% | 3.42% | 4.60% | 3.75% | 5.47% | 4.99% | 5.59% | 4.35% | 5.65% | 5.83% | 6.86% | 5.93% |
NGG National Grid plc | 4.05% | 4.03% | 11.81% | 5.20% | 5.18% | 4.75% | 5.32% | 4.94% | 6.51% | 14.95% | 5.07% | 4.73% |
Financials
NGG vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between National Grid plc and GSK plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NGG vs. GSK - Profitability Comparison
NGG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, National Grid plc reported a gross profit of 4.21B and revenue of 10.78B. Therefore, the gross margin over that period was 39.0%.
GSK - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, GSK plc reported a gross profit of 6.34B and revenue of 8.45B. Therefore, the gross margin over that period was 75.1%.
NGG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, National Grid plc reported an operating income of 4.21B and revenue of 10.78B, resulting in an operating margin of 39.0%.
GSK - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, GSK plc reported an operating income of 2.41B and revenue of 8.45B, resulting in an operating margin of 28.5%.
NGG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, National Grid plc reported a net income of 2.66B and revenue of 10.78B, resulting in a net margin of 24.7%.
GSK - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, GSK plc reported a net income of 437.26M and revenue of 8.45B, resulting in a net margin of 5.2%.
Frequently Asked Questions
NGG and GSK have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GSK has higher volatility (8.74%) compared to NGG (6.64%). In terms of maximum drawdown, NGG dropped -54.85% vs GSK's -55.70%.
GSK currently has the higher Sharpe Ratio (1.68 vs 0.85), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NGG and GSK
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer